BCV Raises €6M Series A

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Research
General Health
Professional Services
Medical Devices
Technology
Other Professional Services
Clinical Trials
Science
Biotechnology
Finance
Other Technology
Health
BCV

More Like This

DRIVEWIRE 24 redefines interventional access by providing an active deflectable tip that controls and steers a range of catheters directly to the target vessels. Whereas conventional access devices are reactive and rely on external forces to reach their target, DRIVEWIRE's active technology selects turns on-demand and handles the complexity of navigating the vascular highway with ease. (Graphic: Business Wire)

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

Business Wire logo

CorFlow Therapeutics AG Completes €44 Million Series B Financing to Support the Advancement of a Novel Diagnostic and Drug Delivery Platform for Microvascular Obstruction (MVO) in Heart Attack Patients

(Credit: INBRAIN Neuroelectronics)

INBRAIN Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer Interface Technology

ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury

ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System

PR Newswire associated0

New4med GmbH Announces First Cases of its novel Basivertebral Nerve Ablation (BVNA)

PR Newswire associated0

Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire

ONWARD® Medical to Highlight Brain-Computer Interface at HLTH Europe Conference